Careers
News & Events
contact
Search
about axogen
about axogen
management team
board of directors
partners
international partners
ethics and conduct
our products
Our products
Avance
®
Nerve Graft
Axoguard
®
Nerve Connector
Axoguard
®
Nerve Protector
Axoguard
®
Nerve Cap
Avive
®
Soft Tissue Membrane
Axotouch
®
Two-Point Discriminator
For patients
patient experiences
About the nervous system
Causes of Nerve Damage
Nerve Damage Treatment Options
Peripheral Nerve Injury Map
Nerve Term Glossary
healthcare professionals
healthcare professionals
Our clinical research
Surgical Technique Videos
Understanding the mechanics of nerve repair
Registration and Licenses
investors
News / Events
Financial Information
Stock Data
SEC Filings
Corporate Governance
Additional Information
13631 Progress Blvd, Suite 400
Alachua, FL 32615
© 2019 Axogen, Inc.
Investors
Overview
News / Events
Overview
Press Releases
Axogen In the News
IR Calendar
Clinical Conferences
Presentations
Email Alerts
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Current Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Additional Info
Contacts
FAQ
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
5/A
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Date
Form
Description
PDF
XBRL
Pages
02/16/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
02/16/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
02/09/21
4
Statement of changes in beneficial ownership of securities
2
02/09/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
EX-99.1
13
01/29/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
01/14/21
8-K
Current report filing
Documents
EX-5.1
5
01/12/21
4
Statement of changes in beneficial ownership of securities
2
01/11/21
8-K
Current report filing
Documents
EX-99.1
EX-99.2
44
01/08/21
424B3
Prospectus filed pursuant to Rule 424(b)(3)
32
01/06/21
8-K
Current report filing
Documents
EX-10.1
41
1
2
3
4
5
6
7
8
9
10